BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30495994)

  • 1. The Strengths and Weaknesses of Current US Policy to Address Pain.
    Gross J; Gordon DB
    Am J Public Health; 2019 Jan; 109(1):66-72. PubMed ID: 30495994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The US Opioid Crisis: Current Federal and State Legal Issues.
    Soelberg CD; Brown RE; Du Vivier D; Meyer JE; Ramachandran BK
    Anesth Analg; 2017 Nov; 125(5):1675-1681. PubMed ID: 29049113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The opioid crisis: Origins, trends, policies, and the roles of pharmacists.
    Chisholm-Burns MA; Spivey CA; Sherwin E; Wheeler J; Hohmeier K
    Am J Health Syst Pharm; 2019 Mar; 76(7):424-435. PubMed ID: 31361827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. U.S. policies relevant to the prescribing of opioid analgesics for the treatment of pain in patients with addictive disease.
    Gilson AM; Joranson DE
    Clin J Pain; 2002; 18(4 Suppl):S91-8. PubMed ID: 12479259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A crisis of opioids and the limits of prescription control: United States.
    Kertesz SG; Gordon AJ
    Addiction; 2019 Jan; 114(1):169-180. PubMed ID: 30039595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving state pain policies: recent progress and continuing opportunities.
    Gilson AM; Joranson DE; Maurer MA
    CA Cancer J Clin; 2007; 57(6):341-53. PubMed ID: 17989129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges with Implementing the Centers for Disease Control and Prevention Opioid Guideline: A Consensus Panel Report.
    Kroenke K; Alford DP; Argoff C; Canlas B; Covington E; Frank JW; Haake KJ; Hanling S; Hooten WM; Kertesz SG; Kravitz RL; Krebs EE; Stanos SP; Sullivan M
    Pain Med; 2019 Apr; 20(4):724-735. PubMed ID: 30690556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioids and Cancer Pain Management in the United States: Public Policy and Legal Challenges.
    Foxwell AM; Uritsky T; Meghani SH
    Semin Oncol Nurs; 2019 Jun; 35(3):322-326. PubMed ID: 31053394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioids May be Appropriate for Chronic Pain.
    Christo PJ
    J Law Med Ethics; 2020 Jun; 48(2):241-248. PubMed ID: 32631179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From political controversy to a technical problem? Fifteen years of opioid substitution treatment in Finland.
    Selin J; Hakkarainen P; Partanen A; Tammi T; Tigerstedt C
    Int J Drug Policy; 2013 Nov; 24(6):e66-72. PubMed ID: 24095679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syringe services programs: An examination of legal, policy, and funding barriers in the midst of the evolving opioid crisis in the U.S.
    Jones CM
    Int J Drug Policy; 2019 Aug; 70():22-32. PubMed ID: 31059965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Damned if they do, damned if they don't: the need for a comprehensive public policy to address the inadequate management of pain.
    Dilcher AJ
    Ann Health Law; 2004; 13(1):81-144, table of contents. PubMed ID: 15002182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Evidence in the US Response to the Opioid Crisis.
    Sharfstein JM; Olsen Y
    Epidemiol Rev; 2020 Jan; 42(1):167-170. PubMed ID: 32975288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The US Congressional "Decade on Pain Control and Research" 2001-2011: A Review.
    Brennan F
    J Pain Palliat Care Pharmacother; 2015 Sep; 29(3):212-27. PubMed ID: 26458017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State policy affecting pain management: recent improvements and the positive impact of regulatory health policies.
    Gilson AM; Maurer MA; Joranson DE
    Health Policy; 2005 Oct; 74(2):192-204. PubMed ID: 16153479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid Crisis: Equianalgesia Dosing Considerations for Home Care Cancer Patients.
    Lee VY; Kowalski SL
    Home Healthc Now; 2019; 37(6):350-352. PubMed ID: 31688470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain and Policy Studies Group: Two Decades of Working to Address Regulatory Barriers to Improve Opioid Availability and Accessibility Around the World.
    Cleary JF; Maurer MA
    J Pain Symptom Manage; 2018 Feb; 55(2S):S121-S134. PubMed ID: 28801005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary: the potential for unintended consequences from public policy shifts in the treatment of pain.
    Haddox JD; Aronoff GM
    J Law Med Ethics; 1998; 26(4):350-2, 263. PubMed ID: 11066894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deploying science to change hearts and minds: Responding to the opioid crisis.
    Walsh SL; Long KQX
    Prev Med; 2019 Nov; 128():105780. PubMed ID: 31319116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A policy mapping analysis of goals, target populations, and punitive notions in the U.S. congressional response to the opioid epidemic.
    Bowen EA; Irish A
    Int J Drug Policy; 2019 Dec; 74():90-97. PubMed ID: 31586775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.